Bausch Health board authorizes up to US$50 million share repurchase program
BHC•Bausch Health's board authorized a common share repurchase program of up to US$50 million to manage potential dilution from employee equity compensation. Repurchases may begin November 3, 2026, and end no later than November 3, 2027.
1. Repurchase program
The program allows purchases of up to 5% of the 374,266,716 common shares outstanding as of October 23, 2026. All repurchased shares will be canceled, and the program may be suspended, modified or discontinued at any time.
